Scientists test new malaria shot in first human volunteers
NCT ID NCT02014727
Summary
This early-stage study tested the safety and immune response of a new malaria vaccine candidate. It involved 66 healthy adults from Europe and Africa, some with prior exposure to malaria. Volunteers received three shots of the experimental vaccine with different immune-boosting additives to see how their bodies reacted and if they produced protective antibodies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA FALCIPARUM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CIC BT 505 de vaccinologie Cochin Pasteur. Hôpital Cochin Bâtiment Lavoisier 27 rue du faubourg St Jacques.
Paris, 75014, France
-
CNRFP
Ouagadougou, Ouagadougou, Burkina Faso
Conditions
Explore the condition pages connected to this study.